Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
Smallridge, R. C, Copland, J. A, Brose, M. S, Wadsworth, J. T, Houvras, Y, Menefee, M. E, Bible, K. C, Shah, M. H, Gramza, A. W, Klopper, J. P, Marlow, L. A, Heckman, M. G, Von Roemeling, R
Published in The journal of clinical endocrinology and metabolism (01.06.2013)
Published in The journal of clinical endocrinology and metabolism (01.06.2013)
Get full text
Journal Article
Efficient method for preparing normal and tumor tissue for RNA extraction
Gramza, A W, Lucas, J M, Mountain, R E, Schuller, D E, Lang, J C
Published in BioTechniques (01.02.1995)
Get more information
Published in BioTechniques (01.02.1995)
Journal Article
Expression of cyclin d1 in squamous-cell carcinomas of the head and neck
Lucas, J, Mountain, R, Gramza, A, Schuller, D, Wilkie, N, Lang, J
Published in International journal of oncology (01.09.1994)
Published in International journal of oncology (01.09.1994)
Get more information
Journal Article
Activity of novel RET inhibitors against RET genotypes associated with medullary thyroid cancer
Gramza, A. W., Patterson, J., Peters, J., Kaufman, M., Wise, S., Flynn, D.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial
Sosa, J. A., Elisei, R., Jarzab, B., Bal, C. S., Koussis, H., Gramza, A. W., Ben-Yosef, R., Gitlitz, B. J., Haugen, B., Karandikar, S. M., Khuri, F. R., Licitra, L. F., Remick, S. C., Marur, S., Lu, C., Ondrey, F. G., Lu, S., Balkissoon, J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article